Cargando…
Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy
Drug delivery and triggered release in tumor cells would realize the ultimate goal of precise cancer treatment. An APE1 triggered DNA nanoprism was designed, aiming at the applications of both drug delivery and precise triggered drug release in cancer cell. We demonstrate that the AP-Prism was succe...
Autores principales: | Liang, Meng, Li, Na, Liu, Fei, Zeng, Nan, Yu, Changyuan, Li, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704400/ https://www.ncbi.nlm.nih.gov/pubmed/35943146 http://dx.doi.org/10.1080/15384101.2022.2108567 |
Ejemplares similares
-
Apurinic/Apyrimidinic Endonuclease 1 and Tyrosyl-DNA Phosphodiesterase 1 Prevent Suicidal Covalent DNA-Protein Crosslink at Apurinic/Apyrimidinic Site
por: Lebedeva, Natalia A., et al.
Publicado: (2021) -
Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma
por: Xie, Jiayin, et al.
Publicado: (2014) -
Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1
por: Simeonov, Anton, et al.
Publicado: (2009) -
Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori
por: Turgimbayeva, Aigerim, et al.
Publicado: (2018) -
Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases
por: Schein, Catherine H, et al.
Publicado: (2002)